{"id":13246,"date":"2019-03-19T12:50:04","date_gmt":"2019-03-19T09:50:04","guid":{"rendered":"http:\/\/www.teise.pro\/?p=13246"},"modified":"2019-03-19T12:54:24","modified_gmt":"2019-03-19T09:54:24","slug":"antikorupcijos-komisija-nauja-vaistu-baziniu-kainu-apskaiciavimo-tvarka-nepasiteisino","status":"publish","type":"post","link":"https:\/\/www.teise.pro\/index.php\/2019\/03\/19\/antikorupcijos-komisija-nauja-vaistu-baziniu-kainu-apskaiciavimo-tvarka-nepasiteisino\/","title":{"rendered":"Antikorupcijos komisija: nauja vaist\u0173 bazini\u0173 kain\u0173 apskai\u010diavimo tvarka nepasiteisino"},"content":{"rendered":"<div class=\"naujienos-paieska border-default primary-border\">\n<div class=\"naujienos-paieska-title toggler\">Seimo Antikorupcijos komisija 2018 m. gruod\u017eio 5 d. pos\u0117dyje nagrin\u0117dama galimus vaistini\u0173 preparat\u0173 kainodaros tr\u016bkumus ir neigiamus vaist\u0173 kain\u0173 poky\u010dius, kreip\u0117si \u012f Speciali\u0173j\u0173 tyrim\u0173 tarnyb\u0105 (STT) d\u0117l vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 bazini\u0173 kain\u0173 ir pacient\u0173 priemok\u0173 u\u017e juos apskai\u010diavimo tvarkos antikorupcinio vertinimo.<\/div>\n<div><\/div>\n<div>STT atlikusi vaist\u0173 bazini\u0173 kain\u0173 nustatymo tvarkos <a href=\"https:\/\/e-seimas.lrs.lt\/portal\/legalAct\/lt\/TAK\/2d983542497211e98bc2ba0c0453c004\" target=\"_blank\" rel=\"noopener\">antikorupcin\u012f vertinim\u0105<\/a> ir apibendrinusi 2018 m. informacij\u0105 apie vaist\u0173 bazines kainas ir pacient\u0173 priemokas, konstatavo, kad Sveikatos apsaugos ministerija, 2018 m. pakeitusi vaist\u0173 bazini\u0173 kain\u0173 apskai\u010diavimo tvark\u0105, galimai pasiek\u0117 tik pacient\u0173 priemok\u0173 ma\u017e\u0117jim\u0105, ta\u010diau vaist\u0173 kainos kilo, o Privalomojo sveikatos draudimo fondo biud\u017eeto (PSDF) taupymas, \u012fsigaliojus pakeitimams, 2018 m. suma\u017e\u0117jo dvigubai. STT prognozuoja, kad pagal 2019 m. I ketvir\u010dio kainyn\u0105, l\u0117\u0161\u0173 apskritai nebebus sutaupyta ir net prognozuojami PSDF biud\u017eeto praradimai.<\/div>\n<div><\/div>\n<\/div>\n<div class=\"naujienos-main-body\">\n<div id=\"document-text-container1\" class=\"document-text-container\">\n<p>Vaist\u0173 bazini\u0173 kain\u0173 apskai\u010diavimo tvarkos antikorupcinis vertinimas parod\u0117, kad sugrupavus vaistinius preparatus pagal j\u0173 stiprum\u0105, buvo sudarytos s\u0105lygos atskiriems tiek\u0117jams pasinaudoti galimybe padidinti vaistini\u0173 preparat\u0173 kainas, d\u0117l to padid\u0117jo bazin\u0117 kaina. Be to, numa\u010dius i\u0161imtis i\u0161 taisykl\u0117s ir leidus kai kuri\u0173 tiek\u0117j\u0173 vaistiniams preparatams ne tik i\u0161likti kainyne, bet j\u0173 bazin\u0119 kain\u0105 apskai\u010diuoti kaip vardini\u0173 vaistini\u0173 preparat\u0173, buvo sudaryta galimyb\u0117 vaist\u0173 tiek\u0117jams naudotis dominuojan\u010dia pad\u0117timi ir \u017einant, kad j\u0173 vaistas yra b\u016btinas ir nepakei\u010diamas, ir jo bazin\u0117 kaina bus perskai\u010diuojama kaip vardinio, tiek\u0117jas gal\u0117jo nema\u017einti Lietuvai taikomos kainos, o prie\u0161ingai \u2013 j\u0105 didinti.<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<p><em>LR Seimo informacija<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Seimo Antikorupcijos komisija 2018 m. gruod\u017eio 5 d. pos\u0117dyje nagrin\u0117dama galimus vaistini\u0173 preparat\u0173 kainodaros tr\u016bkumus ir neigiamus vaist\u0173 kain\u0173 poky\u010dius, kreip\u0117si \u012f Speciali\u0173j\u0173 tyrim\u0173 tarnyb\u0105 (STT) d\u0117l vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 bazini\u0173 kain\u0173 ir pacient\u0173 priemok\u0173 u\u017e juos apskai\u010diavimo tvarkos antikorupcinio vertinimo. STT atlikusi vaist\u0173 bazini\u0173 kain\u0173 nustatymo tvarkos antikorupcin\u012f vertinim\u0105 ir apibendrinusi &hellip;<\/p>\n","protected":false},"author":2,"featured_media":10210,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"episode_type":"","audio_file":"","duration":"","filesize":"","date_recorded":"","explicit":"","block":"","filesize_raw":""},"categories":[27],"tags":[389,196,599,1226],"_links":{"self":[{"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/posts\/13246"}],"collection":[{"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/comments?post=13246"}],"version-history":[{"count":1,"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/posts\/13246\/revisions"}],"predecessor-version":[{"id":13247,"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/posts\/13246\/revisions\/13247"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/media\/10210"}],"wp:attachment":[{"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/media?parent=13246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/categories?post=13246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.teise.pro\/index.php\/wp-json\/wp\/v2\/tags?post=13246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}